Biosensors detect tumors and dengue fever

Biosensors detect tumors and dengue fever
Researchers from the International Islamic University Malaysia (IIUM) have developed a tumor biosensing chip that can help determine the optimal chemotherapy dosage required for a cancer patient. (International Islamic University Malaysia)

Researchers from the International Islamic University Malaysia (IIUM) have developed a tumor biosensing chip that can help determine the optimal chemotherapy dosage required for a cancer patient.

Developed by Prof. Anis Nurashikin Nordin and her team, the miniature chip uses cells derived from cancer patients to screen reactions to different drugs and dosages. The sensor measures the growth and death of the cancer cells electronically and the results are transmitted wirelessly in real time.

Currently, the chip is being tested with lung cancer patients and the research team hopes that it can be used to help cancer patients in the near future.

Sponsored by Infosys

In Conversation with Antonio Neri, President & CEO – Hewlett Packard Enterprise & Salil Parekh, CEO – Infosys

Hear the CEOs of Infosys & HPE discuss the current crisis and how it has accelerated the need for digital transformation for their clients. Connectivity at the Edge, right mix of hybrid cloud, ability to extract data faster than ever before… these are just some of the contributions that HPE and Infosys make to our clients’ digital transformation journey.

RELATED: Biosensors Provide The Key To Non-Invasive Cancer Tests

The chip is one example of the team's efforts to develop precise medical devices for personalized medicine and improving patient outcomes.

Anis and her team have also developed an ultra-sensitive biosensor for early dengue detection. The dengue sensor can detect the mass and electrochemical presence of non-structural protein, NS1, using a low-cost, portable and miniature sensor array. The ability to detect NS1 allows physicians to have an earlier diagnosis for dengue patients and thus prescribe immediate treatment.

Suggested Articles

Revenue forecast for all of 2020 is nearly $10 billion, a 4% improvement

Earlier reports indicated AMD may buy Xilinx for $30 billion, but Xilinx refused to discuss the matter at its Wednesday conference call

AI inference performance metrics matter but most companies are still looking for the financial payoff